MAPT and Alzheimer disease: The AD duration and severity do not correlate well with the concentrations of Aβ and Tau in cerebrospinal fluid (CSF) [6] due to the early saturation of Aβ accumulation in the brain before clinical sign appearance [7,8] and the change of Tau levels during the developmental neurodegeneration [9,10].